last several decades, a remarkable evolution in stent technology, procedures, and adjunctive pharmacology has reduced the treatment gap between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for unprotected left main coronary artery (ULMCA) disease (4) . However, it is still unclear whether there are differences in secular changes over time in the treatment effects between PCI and CABG according to DM status. After overall outcomes between disease groups (DM vs. non-DM) were initially assessed, the adjusted risks for outcomes after PCI versus CABG were evaluated stratified by the presence of DM. We fit weighted Cox proportional hazards models using the propensity scoring that incorporates all the variables regarding baseline characteristics of the patients, with inverse probability of treatment weighting.
Interaction terms were used to test for the statistical significance of 2 treatment effects by the time-waves on outcomes (for the time-by-treatment interaction).
All statistical analyses were performed using R software version 3. Overall, the 3-year rates of MACCE, death, and composite of death, MI, or stroke, but not repeat revascularization, were significantly greater in patients with DM than those without DM ( Table 1 ). The adjusted risks of MACCE, death, and serious composite outcomes were also significantly higher in patients with versus without DM ( Table 2) . Among the non-DM population, patients receiving PCI rather than CABG had higher 3-year rates of MACCE; however, this treatment gap markedly declined over time, with improving outcomes of PCI ( Table 1) . Among the DM population, the 3-year rates of MACCE were higher in the PCI than in the CABG group; however, this treatment gap was persistent over time. In analyses of fitted weighted Cox proportional hazards models using propensity scoring, as compared with crude analyses, the hazard ratio of PCI over CABG for clinical outcomes uniformly increased, which justified the relative benefit of CABG ( Table 2) . In adjusted analyses, overall trends were also consistent. Over time, the adjusted hazard ratio for MACCE after PCI relative to CABG has progressively declined from Repeat revascularization ---0.12 -0.45 *Adjusted hazard ratios were derived from the weighted Cox proportional hazards regression models with the inverse-probability-of-treatment weighting (IPTW). In the IPTW method, weights for patients receiving CABG were the inverse of (1 À propensity score), and weights for patients receiving PCI were the inverse of propensity score. The propensity scores were estimated with multiple logistic-regression analysis, which included baseline covariates (age, sex, body mass index, clinical diagnosis, cardiogenic shock on presentation, left ventricular ejection fraction, atrial fibrillation, hypertension, current smoking, hyperlipidemia, previous myocardial infarction, previous percutaneous coronary intervention, previous coronary artery bypass grafting, previous stroke, previous congestive heart failure, chronic lung disease, chronic kidney disease, peripheral vascular disease, disease extent, presence of right coronary artery disease, left main bifurcation involvement). †Hazard ratios are for the DM group, as compared with the non-DM group. ‡Hazard ratios are for the PCI group, as compared with CABG group. §Three historical time waves were chosen according to the availability of the specific stent types: MACCE ¼ major cardiac and cerebrovascular adverse event(s); other abbreviations as in Table 1 .
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